The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 23, 2013
Filed:
Feb. 07, 2012
Les Paul, Greenville, DE (US);
Amy Foley, Pompton Plains, NJ (US);
Brian F. Ezrow, Quakertown, PA (US);
David B. Snow, Jr., Darien, CT (US);
Ella Berger, Fair Lawn, NJ (US);
Robert S. Epstein, Upper Grandview, NY (US);
Beth Bird, Chicago, IL (US);
Marianne Jacks, Mountain Lakes, NJ (US);
Tej Anand, Chappaqua, NY (US);
Vicente L. Caride, New York, NY (US);
Les Paul, Greenville, DE (US);
Amy Foley, Pompton Plains, NJ (US);
Brian F. Ezrow, Quakertown, PA (US);
David B. Snow, Jr., Darien, CT (US);
Ella Berger, Fair Lawn, NJ (US);
Robert S. Epstein, Upper Grandview, NY (US);
Beth Bird, Chicago, IL (US);
Marianne Jacks, Mountain Lakes, NJ (US);
Tej Anand, Chappaqua, NY (US);
Vicente L. Caride, New York, NY (US);
Medco Health Solutions, Inc., Franklin Lakes, NJ (US);
Abstract
Systems and methods for determining options for reducing spend and/or trend for a prescription drug plan are provided. Based on an analysis of spend and/or trend for the prescription drug plan, a prescription drug spend and/or trend application may determine that an option is available to reduce spend and/or trend. For example, an option may be provided that addresses a primary component of spend and/or trend as determined by the spend and trend application. In another example, an option may be provided that addresses a deviation by the prescription drug plan from a selected performance metric. In yet another example, an option may be provided that addresses a status change for a drug in a marketplace. The spend and/or trend application may optionally project an impact of an option on the prescription drug plan (e.g., financial impact, member impact) using a related model.